Efficacy and Safety of Izokibep, a Novel IL 17A Inhibitor, in Moderate to Severe Hidradenitis Suppurativa: Week 12 Results from a Randomized, Double Blind, Placebo Controlled,[...]

Acelyrin Inc. published this content on September 25, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 28, 2024 at 06:38 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]